PivotalBioVP is a renowned brand in the field of life sciences venture capital. With a capital fund of $685 million, established in 2017, they specialize in investing in privately held companies in North America and Europe. Their focus is on innovative therapeutic products and platforms that address major unmet medical needs.

The investment team at PivotalBioVP brings over 50 years of combined experience in biotech venture capital and company building from top-tier funds. Their expertise and extensive network enable them to evaluate new investment opportunities, build value in their portfolio, and contribute management talent and referrals to their companies. PivotalBioVP invests in companies at all stages of evolution, from creation to mid and late-stage clinical development.

They can lead or co-lead transactions and employ a rigorous investment review process that sets them apart. Their approach allows for syndicate building and positioning companies well for future public offerings or M&A events. With an impressive portfolio and an experienced team, PivotalBioVP is committed to driving innovation and making a significant impact in the life sciences industry.

Contact them today to explore investment opportunities or learn more about their success stories